Promoting Active Living Among People With Metastatic Breast Cancer

NCT ID: NCT07238023

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activity is generally safe for this population and may alleviate symptom burden. Yet, limited interventions are tailored to the unique and needs and preferences of this population. This study aims to evaluate the acceptability and feasibility of a mindfulness- and acceptance-based physical activity program designed to support mental, social, and spiritual well-being among people with metastatic breast cancer. A single group, pretest-posttest trial (N=38) will be conducted to inform scalable strategies to promote active living and enhance quality of life among people with advanced cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metastatic Invasive Breast Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

aerobic physical activity muscle strengthening physical activity mindfulness acceptance telehealth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acceptance- and Mindfulness-Based Intervention

Provision of standard self-regulatory behavior change techniques, plus acceptance and mindfulness-based physical activity promotion

Group Type EXPERIMENTAL

Acceptance- and mindfulness-based physical activity promotion

Intervention Type BEHAVIORAL

This intervention will be delivered over the course of up to 8-12 weeks.

It will include:

1. the provision of a wearable physical activity tracker
2. empirically supported behavior change techniques for promoting physical activity
3. Acceptance and Commitment Therapy-informed didactic content centered on promoting physical activity
4. a social component with game design elements reflecting acceptance and mindfulness practices (i.e., the ability to share responses to "Weekly Challenges" and view and comment on others' entries).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acceptance- and mindfulness-based physical activity promotion

This intervention will be delivered over the course of up to 8-12 weeks.

It will include:

1. the provision of a wearable physical activity tracker
2. empirically supported behavior change techniques for promoting physical activity
3. Acceptance and Commitment Therapy-informed didactic content centered on promoting physical activity
4. a social component with game design elements reflecting acceptance and mindfulness practices (i.e., the ability to share responses to "Weekly Challenges" and view and comment on others' entries).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* having been diagnosed with metastatic breast cancer
* medical clearance from healthcare provider to participate in this study
* life expectancy of at least 6 months as per the participant's healthcare provider
* Eastern Cooperative Oncology Group performance status of or 0 or 1
* being willing and able to use a smartphone and web interface with or without assistance; if assistance is needed, it must be readily available
* adequate visual and hearing acuity to use a smartphone and web interface as indicated by self-report
* adequate motor capacity to use a smartphone and web interface as indicated by self-report
* willingness to download and use study-specific app(s), the Fitbit mobile application (this requires use of a Google Gmail account), and other mobile applications for study purposes as needed
* completed baseline survey

Exclusion Criteria

* contraindications to physical activity (e.g., uncontrolled hypertension or cardiac disease noted by the patient's treating healthcare provider)
* presence of bone metastases deemed unstable by the treating healthcare provider.
* untreated brain metastases
* history of dementia or other major neurocognitive disorder
* received a diagnosed of Major Depressive Disorder within the previous 6 months
* received a diagnosis of a major psychiatric conditions such as bipolar disorder, psychosis, schizophrenia, or alcoholism that could affect the ability to understand and/or complete the study
* currently hospitalized
* enrolled in hospice
* inability to speak, read, and write in English at the 7th grade level
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TSET Health Promotion Research Center

UNKNOWN

Sponsor Role collaborator

University of Oklahoma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael C Robertson, PhD, MPH

Role: CONTACT

Phone: 14052718001

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18941

Identifier Type: -

Identifier Source: org_study_id